| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| erdafitinib | macrophage colony-stimulating factor 1 receptor | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | substrate |
| erdafitinib | fibroblast growth factor receptor 1 | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
0.62 | approved,investigational | inhibitor |
| erdafitinib | fibroblast growth factor receptor 2 | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
1.4 | approved,investigational | inhibitor |
| erdafitinib | fibroblast growth factor receptor 3 | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
1.41 | approved,investigational | inhibitor |
| erdafitinib | fibroblast growth factor receptor 4 | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
0.82 | approved,investigational | inhibitor |
| erdafitinib | vascular endothelial growth factor receptor 2 | small molecule | NA | drugbank , DGIDB | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
0.06 | approved,investigational | substrate,inhibitor |
| erdafitinib | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | substrate |
| erdafitinib | platelet-derived growth factor receptor alpha | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | substrate |
| erdafitinib | platelet-derived growth factor receptor beta | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | substrate |
| erdafitinib | ret proto-oncogene | small molecule | NA | drugbank | Diagnosis[MeSHID:D003933] Neoplasms[MeSHID:D009369] Carcinoma Transitional Cell[MeSHID:D002295] Mutation[MeSHID:D009154] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of urinary bladder[MeSHID:D001749] Lymphoma[MeSHID:D008223] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | substrate |
| click here to return to the previous page | ||||||||